Alpha-synuclein-based models of Parkinson's disease.

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder marked by dopaminergic neuron loss and Lewy body formation.
• While most PD cases are sporadic, genetic factors like SNCA mutations (encoding alpha-synuclein) are implicated.
• Alpha-synuclein is a key protein involved in PD pathogenesis and aggregation.

Purpose of the Study:

• To review mammalian models for Parkinson's disease research.
• To highlight methodologies used in generating alpha-synuclein-based models.
• To discuss strategies for elucidating PD mechanisms.

Main Methods:

• Review of existing literature on Parkinson's disease models.
• Focus on mammalian models including transgenesis and viral vector gene delivery.
• Inclusion of recently developed 'prion-like' models.

Main Results:

• Numerous alpha-synuclein-based models have been developed over two decades.
• These models utilize diverse methodologies for studying PD.
• Mammalian models offer insights into protein aggregation and neurodegeneration.

Conclusions:

• Alpha-synuclein models are crucial for understanding Parkinson's disease progression.
• Current modeling strategies provide opportunities to investigate PD mechanisms.
• Further research using these models can advance therapeutic strategies for Parkinson's disease.